Search - tctmd.com

Displaying 561 - 580 of 2608

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Todd Neale

November 29, 2022

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

New Risk Models Superior to Pretest Probability at Predicting CAD

Yael L. Maxwell

November 15, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Caitlin E. Cox

November 09, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2022

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

New Risk Models Superior to Pretest Probability at Predicting CAD

Many STEMI Patients Not Treated Within National Time Goals

Sizeable Minority of Pregnant Women Have CVD, US Data Show

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

November 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for October 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content